Seres Therapeutics, Inc. (MCRB) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 131.82M |
| Enterprise Value | 169.02M |
| P/E Ratio | -1.16 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 48.12 |
| Price/Book Ratio | 2.06 |
| Enterprise/Revenue | 92.3 |
| Enterprise/EBITDA | -2.26 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -40.89 |
| Operating Margin | -76.41 |
| Return On Assets | -0.4 |
| Return On Equity | -1.27 |
| Revenue | 789,000 |
| Revenue/Share | 0.12 |
| Gross Profit | -3.34M |
| EBITDA | 9.83M |
| Net Income | 5.7M |
| Diluted EPS | 0.64 |
| Total Cash | 29.83M |
| Total Cash/Share | 3.11 |
| Total Debt | 80.5M |
| Total Debt/Equity | 3.04 |
| Current Ratio | 1.65 |
| Book Value Per Share | 2.77 |
| 52-Week Change | -24 |
| 52-Week High | 29.98 |
| 52-Week Low | 5.63 |
| Moving Average 50 Days | 7.77 |
| Moving Average 200 Days | 13.34 |
| Average Volume | 55,017 |
| Shares Outstanding | 9.68M |
| % Held by Institutions | 24.07 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | April 22, 2025 |